Level Biotechnology Inc.
3118.TWO
Price:
$33.3
Market Cap:
$1.08B
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2008-08-20
Stock Exchange
TWO
Ticker
3118.TWO
PE Ratio
[13.43]
ROE
[12.44%]
Current Ratio
[1.63]
Dividend Yield
[5.41%]
Enterprise Value
[846.65M]
Dividend History
The ROE as of December 2025 (TTM) for Level Biotechnology Inc. (3118.TWO) is 12.44%
According to Level Biotechnology Inc.’s latest financial reports and current stock price. The company's current ROE is 12.44%. This represents a change of 301.27% compared to the average of 3.10% of the last 4 quarters.
Level Biotechnology Inc. (3118.TWO) Historical ROE (quarterly & annually)
How has 3118.TWO ROE performed in the past?
The mean historical ROE of Level Biotechnology Inc. over the last ten years is 11.46%. The current 12.44% ROE has changed 8.55% with respect to the historical average. Over the past ten years (40 quarters), 3118.TWO's ROE was at its highest in in the December 2016 quarter at 4.77%. The ROE was at its lowest in in the March 2018 quarter at 1.10%.
Average
11.46%
Median
11.51%
Minimum
7.80%
Maximum
14.94%
Level Biotechnology Inc. (3118.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Level Biotechnology Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.83%
Maximum Annual ROE = 14.94%
Minimum Annual Increase = -40.35%
Minimum Annual ROE = 7.80%
| Year | ROE | Change |
|---|---|---|
| 2024 | 11.58% | 1.11% |
| 2023 | 11.45% | 6.21% |
| 2022 | 10.78% | -13.86% |
| 2021 | 12.51% | 14.14% |
| 2020 | 10.96% | 18.83% |
| 2019 | 9.23% | 18.25% |
| 2018 | 7.80% | -40.35% |
| 2017 | 13.08% | 6.58% |
| 2016 | 12.27% | -17.87% |
| 2015 | 14.94% | -0.84% |
Level Biotechnology Inc. (3118.TWO) Average ROE
How has 3118.TWO ROE performed in the past?
The current ROE of Level Biotechnology Inc. (3118.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.27%
5-year avg
11.46%
10-year avg
11.46%
Level Biotechnology Inc. (3118.TWO) ROE vs. Peers
How is 3118.TWO’s ROE compared to its peers?
Level Biotechnology Inc.’s ROE is less than TCI GENE Inc. (3.64%), greater than LAUNXP Biomedical Co., Ltd (-56.54%), greater than Lukas Biomedical Inc. (-31.59%), greater than Bio Preventive Medicine Corp. (-24.73%), less than BioLASCO Taiwan Co., Ltd. (11.19%), greater than LabTurbo Biotech Corporation (-12.54%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%), greater than NatureWise Biotech & Medicals Corporation (-5.58%), greater than SynCore Biotechnology Co.,Ltd (-18.31%), greater than MegaPro Biomedical Co., Ltd (-91.17%),
| Company | ROE | Market cap |
|---|---|---|
| 3.64% | $984.26M | |
| -56.54% | $1.10B | |
| -31.59% | $1.32B | |
| -24.73% | $1.14B | |
| 11.19% | $813.18M | |
| -12.54% | $1.16B | |
| 9.19% | $1.07B | |
| -5.58% | $1.04B | |
| -18.31% | $905.50M | |
| -91.17% | $994.05M |
Build a custom stock screener for Level Biotechnology Inc. (3118.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Level Biotechnology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Level Biotechnology Inc. (3118.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Level Biotechnology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Level Biotechnology Inc.'s ROE?
How is the ROE calculated for Level Biotechnology Inc. (3118.TWO)?
What is the highest ROE for Level Biotechnology Inc. (3118.TWO)?
What is the 3-year average ROE for Level Biotechnology Inc. (3118.TWO)?
What is the 5-year average ROE for Level Biotechnology Inc. (3118.TWO)?
How does the current ROE for Level Biotechnology Inc. (3118.TWO) compare to its historical average?